This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Oren Beske, Ph.D.
Amalgamator of Business and Biology at ATUM

Profile

Dr. Oren Beske joined ATUM in 2019 and brings nearly 20 years of industry experience to the team. Notably, Dr. Beske was President of Aragen Biosciences, Inc. where he led a multidisciplinary team to bring value added services to the biologics industry. Most recently, he served as the CEO of Alloy Therapeutics, Inc. a start up antibody discovery platform company. Dr. Beske received a BS in Physiology and Biochemistry from CSULB and his Ph.D. in Cell Biology from UC San Francisco.


Agenda Sessions

  • How ATUM's Integrated Bioengineering Pipeline Brought Support for COVID-19 Diagnostics, Therapeutics and Vaccines. From Virtual Information to Master Cell Bank

    On Demand
  • How ATUM's Integrated Bioengineering Pipeline Brought Support for COVID-19 Diagnostics, Therapeutics and Vaccines. From Virtual Information to Master Cell Bank.

    9:00am